A Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of SAR443820 in adult participants with amyotrophic lateral sclerosis, followed by an open-label extension

13003SANOFIACT16970OpenA Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of SAR443820 in adult participants with amyotrophic lateral sclerosis, followed by an open-label extensionACT16970NCT05237284IndustrialAdultTreatmentIIOtherNayar, ShaktiGeorgetown University Medical Center : Gabby LawGUMC Neurology14324Gabby LawGabby Lawgfl11@georgetown.edu2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>